Tanzania - English - Tanzania Medicinces & Medical Devices Authority

bahari pharmacy limited, tanzania - typhoid rapid test -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

bharat biotech international limited, india - typhoid vi conjugate vaccine - vaccine - 25

Zimbabwe - English - Medicines Control Authority

bharat biotech international limited - typhoid vaccine-vi capsular polysaccharide - vaccine - 25mcg/0.5ml

Zimbabwe - English - Medicines Control Authority

bharat biotech international limited - typhoid vaccine-vi capsular polysaccharide - vaccine - 25mcg/0.5ml

Zimbabwe - English - Medicines Control Authority

bharat biotech international limited - typhoid vaccine-vi capsular polysaccharide - vaccine - 25mcg/0.5ml

Zimbabwe - English - Medicines Control Authority

m/s biological e, ltd - typhoid vaccine-vi capsular polysaccharide - vaccine - 25 mcg

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur - vi polysaccharide of salmonella typhi; hepatitis a virus - solution and suspension for suspension for injection in pre-filled syringe - 160/25 - bacterial and viral vaccines, combined; typhoid-hepatitis a

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - hepatitis a virus antigen, quantity: 160 elisa unit - injection, suspension - excipient ingredients: neomycin; formaldehyde; bovine serum albumin; polysorbate 80; aluminium hydroxide hydrate; phenoxyethanol; glucose monohydrate; ascorbic acid; sodium chloride; calcium chloride dihydrate; ferric nitrate nonahydrate; potassium chloride; magnesium sulfate heptahydrate; monobasic potassium phosphate; dibasic sodium phosphate; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; thymine; uracil; sodium xanthine; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; glutamine; glycine; histidine hydrochloride; isoleucine; hydroxyproline; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; dl-threonine; dl-tryptophan; tyrosine disodium; dl-valine; biotin; ergocalciferol; calcium pantothenate; choline chloride; folic acid; inositol; menadione; nicotinic acid; nicotinamide; aminobenzoic acid; pyridoxal hydrochloride; pyridoxine hydrochloride; riboflavine; thiamine hydrochloride; retinol acetate; dl-alpha-tocopheryl phosphate disodium - vivaxim is indicated for simultaneous active immunisation against typhoid fever and hepatitis a virus infections in subject's aged 16 and older.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - salmonella typhi vi polysaccharide, quantity: 0.025 mg - injection, solution - excipient ingredients: monobasic sodium phosphate; phenol; water for injections; sodium chloride; dibasic sodium phosphate dihydrate - for the active immunisation against typhoid fever, in subjects over 5 years of age. indications as at 9 october 2000: typhim vi is indicated for active immunisation against typhoid fever in subjects 2 years of age and over.

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - chloramphenicol sodium succinate (equivalent: chloramphenicol, qty 1 g) - injection, powder for - excipient ingredients: - chloromycetin succinate is specifically indicated for bacterial meningitis, typhoid fever, rickettsial infections, intra ocular infections, other serious infections where bacteriological evidence or clinical judgement indicates that chloramphenicol is appropriate antibiotic.